Bengaluru: Manipal Hospitals reported a 37.3 per cent year-on-year (YoY) growth in revenue to Rs 3,399 crore in the second quarter of FY27.
Ebitda stood at Rs 882 crore, up 29.8 per cent YoY with an ebitda margin of 26.0 per cent, and 26.8 per cent excluding Sahyadri.
Reported Profit after Tax (PAT) was at Rs 285 crore in Q2 FY27. PAT excluding exceptional items stood at Rs 380 crore, up 21.6 per cent YoY.
When excluding Rs 75 crore of post-tax interest on the NCD raised for the Sahyadri acquisition, PAT was Rs 455 crore, up 45.6 per cent, the healthcare major informed.
Sahyadri Hospitals contributed Rs 375 crore in revenue and Rs 73 crore in EBITDA during Q2 FY27.
Consolidated ARPOB stood at Rs 70,600 per day; excluding Sahyadri, ARPOB was Rs 76,600 per day, up 8.5 per cent.
During the quarter, Inpatient volumes grew 35.0 per cent to approximately 169,000 and outpatient volumes rose 27.2 per cent to approximately 1.74 million.
Occupancy improved by 160 basis points year-on-year to 70.1 per cent, with average operational capacity of 7,331 beds and average length of stay of 2.8 days.
The network’s licensed bed capacity as of September 30, 2026 stands at 13,440 beds, following the opening of its 300-licensed-bed Electronic City hospital in Bengaluru.
For H1 FY27, Manipal’s revenue reached Rs 6,490 crore, up 37.7 per cent, and EBITDA reached Rs 1,631 crore, up 28.2 per cent.
Oncology revenue grew 51 per cent YoY, neurosciences 47 per cent and orthopedics 44 per cent, with cardiac sciences, gastroenterology and renal sciences growing 39 per cent, 36 per cent and 38 per cent, respectively, in the half yearly period.
Sahayadri’s half year revenue reached Rs 707 crore, up 17.8 per cent, and EBITDA reached Rs 131 crore, up 24.1 per cent.
Its H1 occupancy was 67 per cent, up 270 basis points, while ARPOB increased 12.5 per cent to Rs 44,100 per day.
Manipal added the Sahayadri’s Integration progressed through the rollout of centralised procurement rates and the addition and enhancement of clinical capability & programs.
“The phased brand transition has been initiated with a Q4 FY27 timeline, while the nine-hospital Pune cluster is being developed as an integrated network with shared leadership, referrals and clinical capabilities,” it said.
Dilip Jose, Managing Director & CEO, Manipal Hospitals, said, “We are pleased that our performance this quarter has been driven by volumes with more patients accessing our care and this we believe is the sustainable option for growth in care delivery. Improved capacity utilisation, particularly in high-acuity specialties continued to be a key driver while maintaining focus on strengthening our clinical capabilities, improving operational performance and building a more integrated healthcare platform.”
